The role of epidemiology in MS research: Past successes, current challenges and future potential

Multiple Sclerosis

Volumn 21, Issue 8, 2015, Pages 969-977

  Simpson, Steve ^a   Taylor, Bruce V ^a   Van Der Mei, Ingrid ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Biome; epidemiology; gene environment interactions; methods; mode of action; multiple sclerosis; review

Indexed keywords

COLECALCIFEROL 24 HYDROXYLASE; HLA DRB1 ANTIGEN; VITAMIN D;

ARTICLE; CASE CONTROL STUDY; CEREBROSPINAL FLUID; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYP24A1 GENE; CYP27B1 GENE; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EPIGENETICS; EPSTEIN BARR VIRUS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE; GENETIC ASSOCIATION; GENOMICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INCIDENCE; MEDICAL RESEARCH; METABOLOMICS; MOBILE PHONE; MORTALITY; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OBSERVATIONAL STUDY; OLIGODENDROGLIA; PHENOTYPE; PREVALENCE; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEX RATIO; SOCIAL MEDIA; SUN EXPOSURE; TRANSCRIPTOMICS; ULTRAVIOLET RADIATION; VITAMIN INTAKE; MOBILE APPLICATION; NERVOUS SYSTEM DEVELOPMENT; REVIEW; VITAMIN SUPPLEMENTATION; EPIDEMIOLOGY; GENETICS; RESEARCH;

EPIDEMIOLOGY; GENE-ENVIRONMENT INTERACTION; HUMANS; MULTIPLE SCLEROSIS; RESEARCH;

EID: 84985943040     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515574896     Document Type: Article

References (69)

1. Santiago O, Gutierrez J, Sorlozano A,. Relation between Epstein-Barr virus and multiple sclerosis: Analytic study of scientific production. Eur J Clin Microbiol Infect Dis 2010; 29: 857-866.
2. Handel AE, Williamson AJ, Disanto G,. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 2010; 5.
3. Handel AE, Williamson AJ, Disanto G,. Smoking and multiple sclerosis: An updated meta-analysis. PLoS One 2011; 6: e16149.
4. Ascherio A, Munger KL, Simon KC,. Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9: 599-612.
5. Davenport CB,. Multiple sclerosis from the standpoint of geographic distribution and race. Association for Research in Nervous and Mental Diseases (ARNMD) 1921; 2: 8-19.
6. Kurtzke JF,. Geography in multiple sclerosis. J Neurol 1977; 215: 1-26.
7. McLeod JG, Hammond SR, Kurtzke JF,. Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: A reassessment. I. Risk of MS by age at immigration. J Neurol 2011; 258: 1140-1149.
8. Kampman MT, Brustad M,. Vitamin D: A candidate for the environmental effect in multiple sclerosis: Observations from Norway. Neuroepidemiology 2008; 30: 140-146.
9. Koch-Henriksen N, Sørensen PS,. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 9: 520-532.
10. Zivadinov R, Iona L, Monti-Bragadin L,. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 2003; 22: 65-74.
11. Acheson ED,. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Neurol Scand 1960; 35: 132-147.
12. Freedman DM, Dosemeci M, Alavanja MC,. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: A case-control study based on death certificates. Occup Environ Med 2000; 57: 418-421.
13. Van der Mei IA, Ponsonby AL, Dwyer T,. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. Brit Med J 2003; 327: 316.
14. Munger KL, Zhang SM, OReilly E,. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-65.
15. Munger KL, Levin LI, Hollis BW,. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Am Med Ass 2006; 296: 2832-2838.
16. Lucas RM, Ponsonby AL, Dear K,. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76: 540-548.
17. Spach KM, Hayes CE,. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005; 175: 4119-4126.
18. The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-828.
19. Smolders J, Peelen E, Thewissen M,. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009; 8: 621-626.
20. Ramagopalan SV, Maugeri NJ, Handunnetthi L,. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1∗1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369.
21. Simpson SL Jr, Taylor B, Blizzard L,. Higher 25-hydroxyvitamin D is associated with lower relapse risk in MS. Ann Neurol 2010; 68: 193-203.
22. Mowry E, Krupp L, Milazzo M,. Vitamin D status is associated with relapse rate in pediatric-onset MS. Ann Neurol 2010; 67: 618-624.
23. Runia TF, Hop WC, De Rijke YB,. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 2012; 79 (3): 261-266.
24. Ascherio A, Munger KL, White R,. Vitamin D as an early predictor of multiple sclerosis activity and progression. J Am Med Assoc Neurol 2014; 71 (3): 306-314.
25. Soilu-Hanninen M, Aivo J, Lindstrom BM,. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2012; 83: 565-571.
26. Shaygannejad V, Janghorbani M, Ashtari F,. Effects of adjunct low-dose vitamin D on relapsing-remitting multiple sclerosis progression: Preliminary findings of a randomized placebo-controlled trial. Mult Scler Int 2012; 2012: 452-541. DOI: 10.1155/2012/452541.
27. Kampman MT, Steffensen LH, Mellgren SI,. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: Exploratory outcomes from a double-blind randomised controlled trial. Mult Scler 2012; 18: 1144-1151.
28. Stein MS, Liu Y, Gray OM,. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 2011; 77: 1611-1618.
29. Smolders J, Hupperts R, Barkhof F,. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo controlled trial. J Neurol Sci 2011; 311 (1-2): 44-49.
30. Dorr J, Ohlraun S, Skarabis H,. Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): Study protocol for a randomized controlled trial. Trials 2012; 13: 15.
31. MS Research Australia. Australia rolls out worlds first MS prevention trial., www.msra.org.au/australiarolls-out-world-first-ms-prevention-trial (2012,. accessed October 2014).
32. Alonso A, Hernan MA,. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 2008; 71: 129-135.
33. Trojano M, Lucchese G, Graziano G,. Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One 2012; 7: e48078.
34. Koch-Henriksen N, Sorensen PS,. Why does the North-South gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere? J Neurol Sci 2011; 311: 58-63.
35. Lucas RM, Valery P, Van der Mei I,. Sun exposure over a lifetime in Australian adults from latitudinally diverse regions. Photochem Photobiol 2013; 89: 737-744.
36. Alonso A, Cook SD, Maghzi AH,. A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler 2011; 17: 550-555.
37. Balfour HH Jr, Sifakis F, Sliman JA,. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis 2013; 208: 1286-1293.
38. Takeuchi K, Tanaka-Taya K, Kazuyama Y,. Prevalence of Epstein-Barr virus in Japan: Trends and future prediction. Pathol Int 2006; 56: 112-116.
39. Palacios N, Alonso A, Bronnum-Hansen H,. Smoking and increased risk of multiple sclerosis: Parallel trends in the sex ratio reinforce the evidence. Ann Epidemiol 2011; 21: 536-542.
40. Staples J, Ponsonby AL, Lim L,. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth and risk of multiple sclerosis in offspring: Longitudinal analysis. Brit Med J 2010; 340: c1640.
41. McGrath JJ, Feron FP, Burne TH,. Vitamin D3: Implications for brain development. J Steroid Biochem Mol Biol 2004; 89-90, 557-560.
42. Eyles DW, Feron F, Cui X,. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 2009; 34: S247-257.
43. McGrath J,. Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 1999; 40: 173-177.
44. Ramagopalan SV, Link J, Byrnes JK,. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009; 73: 2107-2111.
45. Fiddes B, Wason J, Kemppinen A,. Confounding underlies the apparent month of birth effect in multiple sclerosis. Ann Neurol 2013; 73: 714-720.
46. Confavreux C, Hutchinson M, Hours MM,. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339: 285-291.
47. Ponsonby AL, Lucas RM, Van der Mei IA,. Offspring number, pregnancy and risk of a first clinical demyelinating event: The AusImmune Study. Neurology 2012; 78: 867-874.
48. Australian Bureau of Statistics. Births, Australia, 2013. Canberra: Australian Bureau of Statistics, 2014.
49. Frey BN, Dias RS,. Sex hormones and biomarkers of neuroprotection and neurodegeneration: Implications for female reproductive events in bipolar disorder. Bipolar Disord 2014; 16: 48-57.
50. Nicot A,. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 2009; 14: 4477-4515.
51. Koch M, Kingwell E, Rieckmann P,. The natural history of primary progressive multiple sclerosis. Neurology 2009; 73: 1996-2002.
52. Maghzi AH, Etemadifar M, Saadatnia M,. Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran. Eur J Neurol 2007; 14: 403-407.
53. Rovaris M, Judica E, Sastre-Garriga J,. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008; 14: 455-464.
54. Weinshenker BG, Bass B, Rice GP,. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146.
55. Cree BA,. Genetics of primary progressive multiple sclerosis. Handbook Clin Neurol 2014; 122: 211-230.
56. Van der Mei IA, Otahal P, Simpson S Jr, Taylor B,. Meta-analyses to investigate gene-environment interactions in neuroepidemiology. Neuroepidemiology 2014; 42: 39-49.
57. Hart PH, Gorman S, Finlay-Jones JJ,. Modulation of the immune system by UV radiation: More than just the effects of vitamin D? Nat Rev Immunol 2011; 11: 584-596.
58. Manolagas SC, Provvedini DM, Tsoukas CD,. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 1985; 43: 113-122.
59. Buljevac D, Flach HZ, Hop WC,. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002; 125: 952-960.
60. Tremlett H, Van der Mei IA, Pittas F,. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 2008; 31: 271-279.
61. Smolders J, Menheere P, Kessels A,. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008; 14: 1220-1224.
62. Gilligan C, Kypri K, Bourke J,. Social networking versus Facebook advertising to recruit survey respondents: A quasi-experimental study. JMIR Res Protocols 2014; 3: e48.
63. Gundersen DA, ZuWallack RS, Dayton J,. Assessing the feasibility and sample quality of a national random-digit dialing cellular phone survey of young adults. Am J Epidemiol 2014; 179: 39-47.
64. OConnor A, Jackson L, Goldsmith L,. Can I get a retweet please? Health research recruitment and the Twittersphere. J Advanced Nurs 2014; 70: 599-609.
65. Nelson EJ, Hughes J, Oakes JM,. Estimation of geographic variation in human papillomavirus vaccine uptake in men and women: An online survey using Facebook recruitment. J Med Internet Res 2014; 16: e198.
66. Stopponi MA, Alexander GL, McClure JB,. Recruitment to a randomized web-based nutritional intervention trial: Characteristics of participants compared to non-participants. J Med Internet Res 2009; 11: e38.
67. Livingston M, Dietze P, Ferris J,. Surveying alcohol and other drug use through telephone sampling: A comparison of landline and mobile phone samples. BMC Med Res Methodol 2013; 13: 41.
68. Blumberg SJ, Luke JV,. Reevaluating the need for concern regarding noncoverage bias in landline surveys. Am J Public Health 2009; 99: 1806-1810.
69. Hill AB,. The environment and disease: Association or causation? Proc Roy Soc Med 1965; 58: 295-300.